Latest news with #APOG
Yahoo
16 hours ago
- Business
- Yahoo
Apogee Enterprises: Fiscal Q1 Earnings Snapshot
MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Apogee Enterprises Inc. (APOG) on Friday reported a fiscal first-quarter loss of $2.7 million, after reporting a profit in the same period a year earlier. The Minneapolis-based company said it had a loss of 13 cents per share. Earnings, adjusted for one-time gains and costs, were 56 cents per share. The glass products company posted revenue of $346.6 million in the period. Apogee Enterprises expects full-year earnings in the range of $3.80 to $4.20 per share, with revenue in the range of $1.4 billion to $1.44 billion. Apogee Enterprises shares have fallen 44% since the beginning of the year. The stock has dropped 33% in the last 12 months. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on APOG at
Yahoo
2 days ago
- Business
- Yahoo
What To Expect From Apogee's (APOG) Q2 Earnings
Architectural products company Apogee (NASDAQ:APOG) will be reporting earnings this Friday before market open. Here's what to look for. Apogee beat analysts' revenue expectations by 4.2% last quarter, reporting revenues of $345.7 million, down 4.5% year on year. It was a strong quarter for the company, with an impressive beat of analysts' EBITDA estimates and full-year revenue guidance beating analysts' expectations. Is Apogee a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Apogee's revenue to decline 1.6% year on year to $326.1 million, improving from the 8.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.45 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Apogee has missed Wall Street's revenue estimates twice over the last two years. With Apogee being the first among its peers to report earnings this season, we don't have anywhere else to look to get a hint at how this quarter will unravel for building products stocks. However, there has been positive investor sentiment in the segment, with share prices up 2.1% on average over the last month. Apogee's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $55 (compared to the current share price of $39.62). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Sign in to access your portfolio
Yahoo
5 days ago
- Business
- Yahoo
1 Stock Under $50 with Solid Fundamentals and 2 to Ignore
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they're not immune to volatility as many lack the scale advantages of their larger peers. These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one stock under $50 with massive upside potential and two that could be down big. Share Price: $38 Involved in the design of the Apple Store on Fifth Avenue in New York City, Apogee (NASDAQ:APOG) sells architectural products and services such as high-performance glass for commercial buildings. Why Does APOG Fall Short? Sales stagnated over the last five years and signal the need for new growth strategies Projected sales for the next 12 months are flat and suggest demand will be subdued Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 2.8 percentage points At $38 per share, Apogee trades at 9x forward P/E. To fully understand why you should be careful with APOG, check out our full research report (it's free). Share Price: $20.55 With technology that automatically adjusts insulin delivery based on continuous glucose monitoring data, Tandem Diabetes Care (NASDAQ:TNDM) develops and manufactures automated insulin delivery systems that help people with diabetes manage their blood glucose levels. Why Should You Sell TNDM? Disappointing pump shipments over the past two years suggest it might have to lower prices to accelerate growth Earnings per share fell by 42.6% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders Tandem Diabetes's stock price of $20.55 implies a valuation ratio of 34.6x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including TNDM in your portfolio, it's free. Share Price: $34.08 Tracing its roots back to 1889 in Mississippi, Trustmark (NASDAQ:TRMK) is a financial services organization providing banking, wealth management, insurance, and mortgage services across five southeastern states. Why Are We Positive On TRMK? Decent 9.2% annual net interest income growth over the last four years beat most of its peers, showing borrowers find value in its loans Earnings growth has massively outpaced its peers over the last two years as its EPS has compounded at 9.5% annually Balance sheet strength has increased this cycle as its 20.2% annual tangible book value per share growth over the last two years was exceptional Trustmark is trading at $34.08 per share, or 1x forward P/B. Is now a good time to buy? See for yourself in our in-depth research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
11-04-2025
- Business
- Yahoo
Is It Time To Consider Buying Apogee Enterprises, Inc. (NASDAQ:APOG)?
While Apogee Enterprises, Inc. (NASDAQ:APOG) might not have the largest market cap around , it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$71.90 at one point, and dropping to the lows of US$43.52. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Apogee Enterprises' current trading price of US$46.24 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Apogee Enterprises's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Good news, investors! Apogee Enterprises is still a bargain right now. Our valuation model shows that the intrinsic value for the stock is $61.64, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Apogee Enterprises's share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range. See our latest analysis for Apogee Enterprises Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Though in the case of Apogee Enterprises, it is expected to deliver a relatively unexciting earnings growth of 2.9%, which doesn't help build up its investment thesis. Growth doesn't appear to be a main reason for a buy decision for the company, at least in the near term. Are you a shareholder? Even though growth is relatively muted, since APOG is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on APOG for a while, now might be the time to make a leap. Its future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy APOG. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision. If you'd like to know more about Apogee Enterprises as a business, it's important to be aware of any risks it's facing. In terms of investment risks, we've identified 1 warning sign with Apogee Enterprises , and understanding it should be part of your investment process. If you are no longer interested in Apogee Enterprises, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
